Anne-Paule Gimenez-Roqueplo
Gimenez-Roqueplo, Anne-Paule
![Sudoc [ABES], France](/viaf/images/flags/SUDOC.png "Sudoc [ABES], France")
VIAF ID: 209155467 (Personal)
Permalink: http://viaf.org/viaf/209155467
Preferred Forms
-
100 0 _
‡a
Anne-Paule Gimenez-Roqueplo
-
100 1 _
‡a
Gimenez-Roqueplo, Anne-Paule
4xx's: Alternate Name Forms (2)
Works
| Title | Sources |
|---|---|
| Caractérisation des altérations génétiques constitutionnelles et somatiques des phéochromocytomes / paragangliomes |
|
| Characterization of the development of aldosterone-producing adenomas using somatic genomics approaches. |
|
| Développement de nouveaux tests fonctionnels d'aide à l'interpretation des variants de signification biologique inconnue dans le cadre de prédispositions génétiques au cancer. |
|
| Identification of new paraganglioma susceptibility genes. |
|
| Inactivation of the APC gene is constant in adrenocortical tumors from patients with familial adenomatous polyposis but not frequent in sporadic adrenocortical cancers. |
|
| Integrative multi-omics analysis identifies a prognostic miRNA signature and a targetable miR-21-3p/TSC2/mTOR axis in metastatic pheochromocytoma/paraganglioma |
|
| Loss of succinate dehydrogenase activity results in dependency on pyruvate carboxylation for cellular anabolism |
|
| [Malignant hereditary paraganglioma: problems raised by non-functional forms management] |
|
| MAX Mutations Cause Hereditary and Sporadic Pheochromocytoma and Paraganglioma |
|
| MET alterations in biphasic squamoid alveolar papillary renal cell carcinomas and clinicopathological features |
|
| The MITF, p.E318K Variant, as a Risk Factor for Pheochromocytoma and Paraganglioma. |
|
| Mitochondrial Deficiencies in the Predisposition to Paraganglioma |
|
| Mitochondrial succinate is instrumental for HIF1alpha nuclear translocation in SDHA-mutant fibroblasts under normoxic conditions |
|
| Mosaicism in HIF2A-related polycythemia-paraganglioma syndrome. |
|
| The mTORC1 Complex Is Significantly Overactivated in SDHX-Mutated Paragangliomas. |
|
| Nationwide French Study of RET Variants Detected from 2003 to 2013 Suggests a Possible Influence of Polymorphisms as Modifiers |
|
| Oncogenic features of the bone morphogenic protein 7 (BMP7) in pheochromocytoma. |
|
| Oncometabolites-driven tumorigenesis: From genetics to targeted therapy |
|
| Penetrance and clinical consequences of a gross SDHB deletion in a large family |
|
| Peritoneal Implantation of Pheochromocytoma Following Tumor Capsule Rupture During Surgery |
|
| PHACTR1 Is a Genetic Susceptibility Locus for Fibromuscular Dysplasia Supporting Its Complex Genetic Pattern of Inheritance. |
|
| Phaeochromocytoma, new genes and screening strategies. |
|
| Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline |
|
| Pheochromocytoma: When to search a germline defect? |
|
| Pheochromocytomas: the (pseudo)-hypoxia hypothesis. |
|
| Positive Impact of Genetic Test on the Management and Outcome of Patients With Paraganglioma and/or Pheochromocytoma |
|
| Presymptomatic genetic testing in minors at risk of paraganglioma and pheochromocytoma: our experience of oncogenetic multidisciplinary consultation |
|
| Psychological aspects of genetic diagnosis of endocrine tumors |
|
| The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway |
|
| Rapid determination of tricarboxylic acid cycle enzyme activities in biological samples |
|
| Reassessing the clinical spectrum associated with hereditary leiomyomatosis and renal cell carcinoma syndrome in French FH mutation carriers |
|
| [Recent progress in the diagnosis, prognostic evaluation and treatment of pheochromocytomas] |
|
| Relative expression of the RET9 and RET51 isoforms in human pheochromocytomas |
|
| Rethinking pheochromocytomas and paragangliomas from a genomic perspective. |
|
| Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma |
|
| Risk Profile of the RET A883F Germline Mutation: An International Collaborative Study |
|
| Rôle de la signalisation des récepteurs minéralocorticoïde et rétinoïque dans la physiologie du cortex surrénalien et le développement de l’hyperaldostéronisme primaire. |
|
| Rôle de la signalisation PKA dans la zonation de la glande surrénale : modèles génétiques murins et mécanismes post-traductionnels |
|
| Role of cysteine residues in human angiotensinogen. Cys232 is required for angiotensinogen-pro major basic protein complex formation |
|
| Role of PKA signaling in adrenocortical zonation : transgenic mouse models and post-translational mechanisms. |
|
| Screening in asymptomatic SDHx mutation carriers: added value of ¹⁸F-FDG PET/CT at initial diagnosis and 1-year follow-up |
|
| SDH mutations establish a hypermethylator phenotype in paraganglioma. |
|
| SDHA is a tumor suppressor gene causing paraganglioma |
|
| SDHBmutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma |
|
| SDHD Immunohistochemistry: A New Tool to ValidateSDHxMutations in Pheochromocytoma/Paraganglioma |
|
| Somatic NF1 inactivation is a frequent event in sporadic pheochromocytoma |
|
| Spectrum of mutations in Gitelman syndrome |
|
| Stent treatment for pseudocoarctation and refractory hypertension in an elderly patient with Takayasu's arteritis |
|
| Study of molecular and cellular mecanisms responsible for SDHB-associated malignancy in pheochromocytomas and paragangliomas. |
|
| Successful response to pegylated interferon alpha in a patient with recurrent paraganglioma |
|
| The succinate dehydrogenase genetic testing in a large prospective series of patients with paragangliomas. |
|
| Succinate detection using in vivo 1H-MR spectroscopy identifies germline and somatic SDHx mutations in paragangliomas |
|
| Syndrome de Li-Fraumeni,Corticosurrénalomes et autres tumeurs pédiatriques |
|
| Targeted next-generation sequencing detects rare genetic events in pheochromocytoma and paraganglioma |
|
| Tricarboxylic acid cycle dysfunction as a cause of human diseases and tumor formation. |
|
| Unsuspected task for an old team: succinate, fumarate and other Krebs cycle acids in metabolic remodeling |
|
| Usefulness of FDG-PET/CT-Based Radiomics for the Characterization and Genetic Orientation of Pheochromocytomas Before Surgery |
|
| The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL.EVA investigators. |
|
| Vascular and hormonal interactions in primary aldosteronism. |
|
| [Vascular Ehlers-Danlos syndrome]. |
|
| Vascular endothelial growth factor-A is associated with chronic mountain sickness in the Andean population. |
|
| Vascular pattern analysis for the prediction of clinical behaviour in pheochromocytomas and paragangliomas |
|
| Vemurafenib and cobimetinib overcome resistance to vemurafenib in BRAF-mutant ganglioglioma |
|
| The Warburg effect is genetically determined in inherited pheochromocytomas |
|
| Year of diagnosis, features at presentation, and risk of recurrence in patients with pheochromocytoma or secreting paraganglioma |
|
| ਬਚਪਨ ਜਾਂ ਜਵਾਨੀ ਵਿੱਚ ਪ੍ਰਾਇਮਰੀ ਟਿਊਮਰ ਦੇ ਵਿਕਾਸ ਨਾਲ ਸਬੰਧਤ ਮੈਟਾਸਟੈਟਿਕ ਫੀਓਕ੍ਰੋਮੋਸਾਈਟੋਮਾ/ਪੈਰਾਗੈਂਗਲੀਓਮਾ: SDHB ਪਰਿਵਰਤਨ ਲਈ ਮਹੱਤਵਪੂਰਨ ਲਿੰਕ |
|
